Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06223633 · ClinicalTrials.gov registry record · NA
PK(Pharmacokinetic) Papyrus Covered Coronary Stent System
A NA study, sponsored by Methodist Health System.
- Recruiting
- Registry status
- NA
- Development phase
- 41
- Enrollment target
NCT06223633: Recruiting NA study, sponsored by Methodist Health System.
NCT06223633 is a NA study that is actively recruiting participants, run by Methodist Health System. The registered enrollment target is 41 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06223633, a NA study, is actively recruiting participants, sponsored by Methodist Health System.
- RECRUITING
- Registry status
- NA
- Development phase
- 41 participants
- Enrollment target
Study Summary
The PK Papyrus Covered Coronary Stent System is a coronary stent being used at Methodist Dallas Medical Center for patients with coronary perforations.
Primary Outcome
Number of patients with PK Papyrus being treated for acute perforations of native coronary arteries and bypass grafts in vessels.
Interventions
- DEVICE PK Papyrus Covered Coronary Stent System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2023-08-10 |
| Est. Completion | 2028-08 |
| Phase | NA |
What NCT06223633 shows while recruiting
NCT06223633 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 41 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which PK Papyrus Covered Coronary Stent System is the first listed.
NCT06223633 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06223633 about?
NCT06223633 is a clinical study titled "PK(Pharmacokinetic) Papyrus Covered Coronary Stent System". The PK Papyrus Covered Coronary Stent System is a coronary stent being used at Methodist Dallas Medical Center for patients with coronary perforations.
What is the current status of trial NCT06223633?
This trial is currently recruiting. It is a NA study. The enrollment target is 41 participants. The study started on 2023-08-10. Estimated completion is 2028-08.
What interventions are being tested in trial NCT06223633?
The interventions under investigation include: PK Papyrus Covered Coronary Stent System (DEVICE).
Who is sponsoring clinical trial NCT06223633?
This trial is sponsored by Methodist Health System, which has 125 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06223633's enrollment target sits among peer trials
41 1446th of 2000 higher than 554 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03449238 · 41 participants · Phase 1
Pembrolizumab And Stereotactic Radiosurgery (Srs) Of Selected Brain Metastases In Breast Cancer Patients
- NCT03900793 · 41 participants · Phase 1
Losartan + Sunitinib in Treatment of Osteosarcoma
- NCT04082520 · 41 participants · Phase 2
Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy
- NCT04220190 · 41 participants · Phase 2
RAPA-501 Therapy for ALS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI